Hong Kong: 4 Dead, 3 in ICU after receiving Sinovac vaccine (Updated)



Serious adverse reactions of Sinovac COVID-19 vaccine in HK are within the expected range: experts No evidence found to link deaths with vaccines: experts

By Leng Shumei and Chen Qingqing Published: Mar 09, 2021 12:01 AM

A Hong Kong expert team said Monday that they deemed that the second death case in the city following vaccination of Sinovac vaccines was not related to the vaccine as the autopsy report showed that the cause of death of the recipient, a 55-year-old woman, was myocardial infarction and she had an aortic laceration. 

The woman accepted the Sinovac vaccine on March 2 and died on Saturday from a stroke. An autopsy report showed that she had serious chronic disease like high blood pressure and high cholesterol, Ivan Hung Fan Ngai, a co-convener of the committee assessing clinical cases related to vaccines in Hong Kong, said at a press conference on Monday.  

A total of 91,800 doses of COVID-19 vaccines developed by Sinovac and 1,200 doses developed by BioNTech have been administered in Hong Kong as of Sunday, and 64 percent of the vaccinated population are people aged 60 and above, Ronald Lam Man-kin, Controller of the Centre for Health Protection of the Department of Health said at the press conference.  

As of 4 pm Saturday, 16 non-serious cases, like fever and headaches, and 45 other non-serious cases with susceptible adverse effects that need to be hospitalized have been reported to the authorities, Lam said.  

Two susceptible adverse effect cases have also been reported between March 6 and 8, with the two recipients still accepting treatment in the Intensive Care Department. But the experts decided that their symptoms were not caused by the vaccines after reviewing their materials, Hung said.

According to Hung, the first susceptible adverse effect case is an 80-year-old man who is currently in danger. He has diabetes and previously had a stroke.

The second case is a 72-year-old woman. Documents show that her symptoms are related to the suspension of insulin by herself, Lee Cheuk Kwong, another co-convener of the committee, said.

Another susceptible death has been reported on Monday – a 71-year-old man who accepted the first shot on March 3, Lee said, noting that the committee would review the information and decide the cause of the man’s death after autopsy.







9 March 2021

Sinovac’s death rate is 0.00002398o81 (2 out of 83,400)

Pfizer and Moderna,s death rate is 0.00001383333 (996 out of 72,000,000)


2 Dead, 2 in ICU After 83,400 Receive Sinovac Vaccines in Hong Kong

BY NICOLE HAO March 8, 2021 Updated: March 8, 2021

Two Hong Kong residents are in serious condition after receiving China’s Sinovac COVID-19 vaccines, the Hong Kong government announced on Sunday, after a 55-year-old woman with chronic illness died four days after receiving her vaccine—the second related death in the city.

COVID-19 is the disease caused by the CCP (Chinese Communist Party) virus, commonly known as the novel coronavirus.

On Sunday, 8,100 people were vaccinated with Sinovac’s CoronaVac vaccine, which was 82.3 percent of the daily vaccination appointments, according to the city’s Health Department.

But two residents were left in serious condition after vaccination on Saturday and had to be transferred to the intensive care unit (ICU). According to local media reports, two others were sent to hospitals after suffering a milder adverse reaction to the vaccine.

On Saturday, three people were also admitted to hospital after receiving the vaccine. All patients suffered mild reactions and were discharged being treated. The symptoms included skin rash, heart discomfort, dizziness, high blood pressure, and trembling.

A total of 83,400 people had received CoronaVac vaccinations in the city by Saturday.

The health department has said that the mild conditions were caused by the vaccine, while the cause of the deaths and serious reactions were still unclear.

Hong Kong’s Secretary for Health and Food Sophia Chan told a local radio program that Hongkongers can consult their family doctors before booking a COVID-19 vaccination if they have any concerns.

2 Deaths

The Hong Kong Health Department confirmed on Saturday that the second death, the 55-year-old woman, was due to an acute stroke on Friday.

According to the department, the woman had a history of high blood pressure, high blood lipids, and proteinuria, but still could work.

On March 2, the woman received the first dose of CoronaVac at a local community vaccination center. At 7:00 p.m. on Friday, she was working her usual job when she lost control over the left side of her body. She was rushed to hospital by ambulance and diagnosed with a stroke. She passed away at 4:51 a.m. on Saturday morning.

It’s unclear whether the vaccine contributed to the woman’s death. The authorities said they would perform an autopsy and investigate the cause of death.

The first death in Hong Kong was a 63-year-old man with a history of diabetes. He received a Sinovac vaccine on Feb. 26 and died on Feb. 28. The Hong Kong administration has said his death was not caused by the vaccination.

2 in Serious Condition

The first ICU case is an 80-year-old man who has a history of diabetes, carotid atherosclerosis, hypertension, and stroke. He received the vaccine on Monday and called for an ambulance on Saturday due to chest pain. He was in a very serious condition on Sunday after not responding well to treatment, according to the department.

The second ICU case is a 72-year-old woman, who also has a history of diabetes, hyperlipidaemia, hypertension, and hypothyroidism. She received the vaccine on Saturday but skipped two doses of insulin that she took every day when she felt unwell after the vaccination. When her condition declined Sunday morning, her family sent her to the hospital where they found she had severe diabetic ketoacidosis.


Chinese authorities have approved three types of COVID-19 vaccines for emergency use, which include CoronaVac and two inactivated virus vaccines from Sinopharm, but only for people aged 18 to 59, saying that “other age groups need to wait for the vaccines’ further clinical trials.”

However, the Hong Kong government approved CoronaVac and suggested that seniors be vaccinated.

The efficacy of Sinovac’s CoronaVac was found to be 50.4 percent in its last-stage clinical vaccine trials in Brazil—just barely passing the WHO’s 50 percent threshold for regulatory approval. The rate is also lower than the U.S.-developed vaccines, with Pfizer-BioNTech’s at 95 percent, and Moderna’s at 94.1 percent. Elderly deaths have been reported in those who have received Pfizer and Moderna vaccines. But so far, the U.S. CDC says that investigations have shown no link between deaths and vaccines.

On Feb. 14, a 33-year-old Indonesian nurse died of COVID-19. She had received one shot of the CoronaVac vaccine on Jan. 28. At that time, she was healthy, according to her manager.

For more:






This entry was posted in Uncategorized and tagged . Bookmark the permalink.

2 Responses to Hong Kong: 4 Dead, 3 in ICU after receiving Sinovac vaccine (Updated)

  1. Pingback: Pro CCP message on WhatsApp on the wonders of Sinovac… | weehingthong

  2. Pingback: Indonesian Doctors Allegedly Died from Sinovac While Hundreds of Health Workers Test Positive after Receiving the Jab - eClassifie

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s